Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-17

Clinical Trial Update: The Effect of Fluticasone/Salmeterol Combination on Exertional Breathlessness in Patients With Mild COPD [NA]

View source ↗

Summary

A completed clinical trial evaluated whether the fluticasone/salmeterol combination affects exertional breathlessness in patients with mild chronic obstructive …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone/Salmeterol (fluticasone/salmeterol)

Snippet

Sponsor: Queen's University | Conditions: COPD | NA | Status: COMPLETED